Article
Systemic ligand-mimicking bioparticles cross the blood-brain barrier and reduce growth of…
medRxiv · 2021 · Alonso-Valenteen, F.; Medina-Kauwe, L. K.
Key facts
| Title | Systemic ligand-mimicking bioparticles cross the blood-brain barrier and reduce growth of intracranial triple-negative breast cancer using the human epidermal growth factor receptor 3 (HER3) to mediate both routes |
|---|---|
| First author | Alonso-Valenteen, F.; Medina-Kauwe, L. K. |
| Journal | medRxiv |
| Published | Jun 7, 2021 |
| DOI | 10.1101/2021.06.07.446634 |
| Devices mentioned | K842496 |
| Product codes mentioned | JXR |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1